{"audit_author": [{"name": "Groebke-Zbinden, K.", "pdbx_ordinal": 1}, {"name": "Banner, D.W.", "pdbx_ordinal": 2}, {"name": "Benz, J.M.", "pdbx_ordinal": 3}, {"name": "Blasco, F.", "pdbx_ordinal": 4}, {"name": "Decoret, G.", "pdbx_ordinal": 5}, {"name": "Himber, J.", "pdbx_ordinal": 6}, {"name": "Kuhn, B.", "pdbx_ordinal": 7}, {"name": "Panday, N.", "pdbx_ordinal": 8}, {"name": "Ricklin, F.", "pdbx_ordinal": 9}, {"name": "Risch, P.", "pdbx_ordinal": 10}, {"name": "Schlatter, D.", "pdbx_ordinal": 11}, {"name": "Stahl, M.", "pdbx_ordinal": 12}, {"name": "Unger, R.", "pdbx_ordinal": 13}, {"name": "Haap, W.", "pdbx_ordinal": 14}], "cell": {"angle_alpha": 90.0, "angle_beta": 90.0, "angle_gamma": 90.0, "length_a": 105.54, "length_b": 105.54, "length_c": 49.79, "zpdb": 8}, "citation": [{"country": "FR", "id": "primary", "journal_abbrev": "Eur.J.Med.Chem.", "journal_id_astm": "EJMCA5", "journal_id_csd": "0493", "journal_id_issn": "0223-5234", "journal_volume": "44", "page_first": "2787", "pdbx_database_id_doi": "10.1016/J.EJMECH.2008.12.025", "pdbx_database_id_pub_med": 19200624, "rcsb_authors": ["Zbinden, K.G.", "Anselm, L.", "Banner, D.W.", "Benz, J.M.", "Blasco, F.", "Decoret, G.", "Himber, J.", "Kuhn, B.", "Panday, N.", "Ricklin, F.", "Risch, P.", "Schlatter, D.", "Stahl, M.", "Thomi, S.", "Unger, R.", "Haap, W."], "rcsb_is_primary": "Y", "rcsb_journal_abbrev": "Eur J Med Chem", "title": "Design of Novel Aminopyrrolidine Factor Xa Inhibitors from a Screening Hit.", "year": 2009}], "diffrn": [{"ambient_temp": 100.0, "crystal_id": "1", "id": "1"}], "diffrn_detector": [{"detector": "CCD", "diffrn_id": "1", "pdbx_collection_date": "2005-02-21T00:00:00+0000", "type": "MARRESEARCH"}], "diffrn_radiation": [{"diffrn_id": "1", "pdbx_diffrn_protocol": "SINGLE WAVELENGTH", "pdbx_monochromatic_or_laue_ml": "M", "pdbx_scattering_type": "x-ray", "wavelength_id": "1"}], "diffrn_source": [{"diffrn_id": "1", "pdbx_synchrotron_beamline": "X06SA", "pdbx_synchrotron_site": "SLS", "pdbx_wavelength": "1.0072", "source": "SYNCHROTRON", "type": "SLS BEAMLINE X06SA"}], "entry": {"id": "2VWN"}, "exptl": [{"crystals_number": 1, "method": "X-RAY DIFFRACTION"}], "exptl_crystal": [{"density_matthews": 2.15, "density_percent_sol": 42.8, "description": "NONE", "id": "1"}], "pdbx_audit_revision_details": [{"data_content_type": "Structure model", "ordinal": 1, "provider": "repository", "revision_ordinal": 1, "type": "Initial release"}], "pdbx_audit_revision_group": [{"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 1, "revision_ordinal": 2}, {"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 2, "revision_ordinal": 3}], "pdbx_audit_revision_history": [{"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 0, "ordinal": 1, "revision_date": "2009-07-07T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 1, "ordinal": 2, "revision_date": "2011-05-08T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 2, "ordinal": 3, "revision_date": "2011-07-13T00:00:00+0000"}], "pdbx_database_related": [{"content_type": "unspecified", "db_id": "1WU1", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL]CARBONYL]PIPERAZINE"}, {"content_type": "unspecified", "db_id": "2J34", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2BQ7", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43"}, {"content_type": "unspecified", "db_id": "2W3K", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1"}, {"content_type": "unspecified", "db_id": "2VWO", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1XKA", "db_name": "PDB", "details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"content_type": "unspecified", "db_id": "1NFW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR209685"}, {"content_type": "unspecified", "db_id": "2GD4", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX"}, {"content_type": "unspecified", "db_id": "2VVV", "db_name": "PDB", "details": "AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1MSX", "db_name": "PDB", "details": "HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C-METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR AND MD SIMULATIONS."}, {"content_type": "unspecified", "db_id": "1LPG", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79."}, {"content_type": "unspecified", "db_id": "2VVU", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1P0S", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH ECOTIN M84R"}, {"content_type": "unspecified", "db_id": "2G00", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE"}, {"content_type": "unspecified", "db_id": "1MQ6", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA"}, {"content_type": "unspecified", "db_id": "1XKB", "db_name": "PDB", "details": "FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID"}, {"content_type": "unspecified", "db_id": "1IQE", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590"}, {"content_type": "unspecified", "db_id": "1G2M", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2VH0", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS"}, {"content_type": "unspecified", "db_id": "1NFY", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR200095"}, {"content_type": "unspecified", "db_id": "2UWL", "db_name": "PDB", "details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"content_type": "unspecified", "db_id": "2BOK", "db_name": "PDB", "details": "FACTOR XA - CATION"}, {"content_type": "unspecified", "db_id": "1LPZ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41."}, {"content_type": "unspecified", "db_id": "1HCG", "db_name": "PDB", "details": "BLOOD COAGULATION FACTOR XA"}, {"content_type": "unspecified", "db_id": "2W3I", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2"}, {"content_type": "unspecified", "db_id": "1Z6E", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN"}, {"content_type": "unspecified", "db_id": "2JKH", "db_name": "PDB", "details": "FACTOR XA - CATION INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2UWP", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1G2L", "db_name": "PDB", "details": "FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1NFU", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR132747"}, {"content_type": "unspecified", "db_id": "2BQ6", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21"}, {"content_type": "unspecified", "db_id": "1FAX", "db_name": "PDB", "details": "COAGULATION FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1IQF", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165"}, {"content_type": "unspecified", "db_id": "1NL8", "db_name": "PDB", "details": "THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX"}, {"content_type": "unspecified", "db_id": "1IQG", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159"}, {"content_type": "unspecified", "db_id": "1IQH", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143"}, {"content_type": "unspecified", "db_id": "1LQD", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45."}, {"content_type": "unspecified", "db_id": "2UWO", "db_name": "PDB", "details": "SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA"}, {"content_type": "unspecified", "db_id": "1C5M", "db_name": "PDB", "details": "STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"}, {"content_type": "unspecified", "db_id": "1IOE", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532"}, {"content_type": "unspecified", "db_id": "1F0S", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707"}, {"content_type": "unspecified", "db_id": "1F0R", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815"}, {"content_type": "unspecified", "db_id": "1MQ5", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA"}, {"content_type": "unspecified", "db_id": "2BMG", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50"}, {"content_type": "unspecified", "db_id": "1IQN", "db_name": "PDB", "details": "HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192"}, {"content_type": "unspecified", "db_id": "2BQW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45"}, {"content_type": "unspecified", "db_id": "1IQM", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471"}, {"content_type": "unspecified", "db_id": "1EZQ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515"}, {"content_type": "unspecified", "db_id": "2VWL", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "2VH6", "db_name": "PDB", "details": "STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS"}, {"content_type": "unspecified", "db_id": "1FJS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED WITH FACTOR XA"}, {"content_type": "unspecified", "db_id": "1LPK", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125."}, {"content_type": "unspecified", "db_id": "2J4I", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1NFX", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH RPR208944"}, {"content_type": "unspecified", "db_id": "1IQJ", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124"}, {"content_type": "unspecified", "db_id": "2J94", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2J95", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2CJI", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2BOH", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1"}, {"content_type": "unspecified", "db_id": "2J38", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "2VVC", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "2W26", "db_name": "PDB", "details": "FATOR XA IN COMPLEX WITH BAY59-7939"}, {"content_type": "unspecified", "db_id": "1IQI", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125"}, {"content_type": "unspecified", "db_id": "2VWM", "db_name": "PDB", "details": "AMINOPYRROLIDINE FACTOR XA INHIBITOR"}, {"content_type": "unspecified", "db_id": "1KYE", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3-CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE"}, {"content_type": "unspecified", "db_id": "1IQK", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113"}, {"content_type": "unspecified", "db_id": "1V3X", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE"}, {"content_type": "unspecified", "db_id": "2FZZ", "db_name": "PDB", "details": "FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7- ONE"}, {"content_type": "unspecified", "db_id": "2J2U", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX"}, {"content_type": "unspecified", "db_id": "1KSN", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH FXV673"}, {"content_type": "unspecified", "db_id": "1IQL", "db_name": "PDB", "details": "HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476"}], "pdbx_database_status": {"deposit_site": "PDBE", "pdb_format_compatible": "Y", "process_site": "PDBE", "recvd_initial_deposition_date": "2008-06-26T00:00:00+0000", "status_code": "REL"}, "pdbx_vrpt_summary": {"babinet_b": 267.984, "babinet_k": 0.547, "dcc_r": 0.19, "eds_r": 0.19, "fo_fc_correlation": 0.958, "pdb_r": 0.19, "wilson_baniso": "[20.721,20.721,19.820,0.000,0.000,0.000]", "wilson_bestimate": 20.402, "absolute_percentile_dccrfree": 58.0, "absolute_percentile_clashscore": 48.3, "absolute_percentile_percent_rsrzoutliers": 12.3, "absolute_percentile_percent_ramachandran_outliers": 100.0, "absolute_percentile_percent_rotamer_outliers": 90.8, "acentric_outliers": 0, "angles_rmsz": 0.66, "attempted_validation_steps": "molprobity,validation-pack,xtriage,eds,mogul,buster-report,percentiles,writexml", "bonds_rmsz": 0.54, "bulk_solvent_b": 65.581, "bulk_solvent_k": 0.383, "ccp4version": "7.0.044 (Gargrove)", "centric_outliers": 0.0, "clashscore": 6.01, "data_anisotropy": 0.044, "data_completeness": 99.49, "high_resol_relative_percentile_dccrfree": 1.6, "high_resol_relative_percentile_clashscore": 1.6, "high_resol_relative_percentile_percent_rsrzoutliers": 1.6, "high_resol_relative_percentile_percent_ramachandran_outliers": 1.6, "high_resol_relative_percentile_percent_rotamer_outliers": 1.6, "ligands_for_buster_report": "yes", "low_resol_relative_percentile_dccrfree": 1.64, "low_resol_relative_percentile_clashscore": 1.64, "low_resol_relative_percentile_percent_rsrzoutliers": 1.64, "low_resol_relative_percentile_percent_ramachandran_outliers": 1.64, "low_resol_relative_percentile_percent_rotamer_outliers": 1.64, "num_hreduce": 2194.0, "num_pdbids_absolute_percentile_dccrfree": 130704, "num_pdbids_absolute_percentile_clashscore": 141614, "num_pdbids_absolute_percentile_percent_rsrzoutliers": 127900, "num_pdbids_absolute_percentile_percent_ramachandran_outliers": 138981, "num_pdbids_absolute_percentile_percent_rotamer_outliers": 138945, "num_pdbids_relative_percentile_dccrfree": 4693, "num_pdbids_relative_percentile_clashscore": 5002, "num_pdbids_relative_percentile_percent_rsrzoutliers": 4609, "num_pdbids_relative_percentile_percent_ramachandran_outliers": 4888, "num_pdbids_relative_percentile_percent_rotamer_outliers": 4887, "num_angles_rmsz": 3078, "num_bonds_rmsz": 2287, "num_free_reflections": 1835, "num_miller_indices": 36755, "percent_rsrzoutliers": 7.86, "percent_free_reflections": 4.99, "percent_ramachandran_outliers": 0.0, "percent_rotamer_outliers": 0.42, "percentilebins": ["all", "1.61", "xray"], "protein_dnarnaentities": "1,2", "refmac_version": "5.8.0158", "relative_percentile_dccrfree": 25.1, "relative_percentile_clashscore": 29.2, "relative_percentile_percent_rsrzoutliers": 10.2, "relative_percentile_percent_ramachandran_outliers": 100.0, "relative_percentile_percent_rotamer_outliers": 84.0, "report_creation_date": "May 26, 2020 -- 09:54 am BST", "restypes_notchecked_for_bond_angle_geometry": ["H25", "NA", "CA", "CL"], "trans_nsc": "The largest off-origin peak in the Patterson function is 6.36% of the height of the origin peak. No significant pseudotranslation is detected.", "twin_l": 0.485, "twin_l2": 0.315, "xtriage_input_columns": "F_meas_au,F_meas_sigma_au", "bfactor_type": "FULL", "dccrfree": 0.23, "dccrefinement_program": "REFMAC", "edsresolution": 1.61, "edsresolution_low": 18.66, "iover_sigma": "2.32(1.61A)", "pdbrfree": 0.23, "pdbdeposition_date": "2008-06-26T00:00:00+0000", "pdbresolution": 1.61, "pdbresolution_low": 74.54, "pdbrevision_date": "2011-07-13T00:00:00+0000", "pdbrevision_number": 3.0}, "rcsb_accession_info": {"deposit_date": "2008-06-26T00:00:00+0000", "has_released_experimental_data": "N", "initial_release_date": "2009-07-07T00:00:00+0000", "major_revision": 1, "minor_revision": 2, "revision_date": "2011-07-13T00:00:00+0000", "status_code": "REL"}, "rcsb_entry_container_identifiers": {"assembly_ids": ["1", "2", "3"], "entity_ids": ["1", "2", "3", "4", "5", "6", "7"], "entry_id": "2VWN", "model_ids": [1], "non_polymer_entity_ids": ["3", "4", "5", "6"], "polymer_entity_ids": ["1", "2"], "rcsb_id": "2VWN", "pubmed_id": 19200624}, "rcsb_entry_info": {"assembly_count": 3, "branched_entity_count": 0, "cis_peptide_count": 0, "deposited_atom_count": 2523, "deposited_hydrogen_atom_count": 0, "deposited_model_count": 1, "deposited_modeled_polymer_monomer_count": 280, "deposited_nonpolymer_entity_instance_count": 6, "deposited_polymer_entity_instance_count": 2, "deposited_polymer_monomer_count": 296, "deposited_solvent_atom_count": 240, "deposited_unmodeled_polymer_monomer_count": 16, "diffrn_radiation_wavelength_maximum": 1.0072, "diffrn_radiation_wavelength_minimum": 1.0072, "disulfide_bond_count": 8, "entity_count": 7, "experimental_method": "X-ray", "experimental_method_count": 1, "inter_mol_covalent_bond_count": 0, "inter_mol_metalic_bond_count": 16, "molecular_weight": 33.88, "na_polymer_entity_types": "Other", "nonpolymer_bound_components": ["CA", "NA"], "nonpolymer_entity_count": 4, "nonpolymer_molecular_weight_maximum": 0.49, "nonpolymer_molecular_weight_minimum": 0.02, "polymer_composition": "heteromeric protein", "polymer_entity_count": 2, "polymer_entity_count_dna": 0, "polymer_entity_count_rna": 0, "polymer_entity_count_nucleic_acid": 0, "polymer_entity_count_nucleic_acid_hybrid": 0, "polymer_entity_count_protein": 2, "polymer_entity_taxonomy_count": 2, "polymer_molecular_weight_maximum": 27.17, "polymer_molecular_weight_minimum": 6.06, "polymer_monomer_count_maximum": 241, "polymer_monomer_count_minimum": 55, "resolution_combined": [1.61], "selected_polymer_entity_types": "Protein (only)", "software_programs_combined": ["MOLREP", "REFMAC", "XDS"], "solvent_entity_count": 1, "structure_determination_methodology": "experimental", "structure_determination_methodology_priority": 10, "diffrn_resolution_high": {"provenance_source": "Depositor assigned", "value": 1.61}}, "rcsb_primary_citation": {"country": "FR", "id": "primary", "journal_abbrev": "Eur.J.Med.Chem.", "journal_id_astm": "EJMCA5", "journal_id_csd": "0493", "journal_id_issn": "0223-5234", "journal_volume": "44", "page_first": "2787", "pdbx_database_id_doi": "10.1016/J.EJMECH.2008.12.025", "pdbx_database_id_pub_med": 19200624, "rcsb_authors": ["Zbinden, K.G.", "Anselm, L.", "Banner, D.W.", "Benz, J.M.", "Blasco, F.", "Decoret, G.", "Himber, J.", "Kuhn, B.", "Panday, N.", "Ricklin, F.", "Risch, P.", "Schlatter, D.", "Stahl, M.", "Thomi, S.", "Unger, R.", "Haap, W."], "rcsb_journal_abbrev": "Eur J Med Chem", "title": "Design of Novel Aminopyrrolidine Factor Xa Inhibitors from a Screening Hit.", "year": 2009}, "refine": [{"aniso_b11": -0.01, "aniso_b12": 0.0, "aniso_b13": 0.0, "aniso_b22": -0.01, "aniso_b23": 0.0, "aniso_b33": 0.02, "correlation_coeff_fo_to_fc": 0.96, "correlation_coeff_fo_to_fc_free": 0.939, "details": "HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.", "ls_rfactor_rfree": 0.228, "ls_rfactor_rwork": 0.191, "ls_rfactor_obs": 0.193, "ls_dres_high": 1.61, "ls_dres_low": 74.54, "ls_number_reflns_rfree": 1835, "ls_number_reflns_obs": 34921, "ls_percent_reflns_rfree": 5.0, "ls_percent_reflns_obs": 99.4, "overall_sub": 1.867, "overall_suml": 0.066, "pdbx_rfree_selection_details": "RANDOM", "pdbx_diffrn_id": ["1"], "pdbx_ls_cross_valid_method": "THROUGHOUT", "pdbx_method_to_determine_struct": "MOLECULAR REPLACEMENT", "pdbx_overall_esur": 0.1, "pdbx_overall_esurfree": 0.1, "pdbx_refine_id": "X-RAY DIFFRACTION", "pdbx_solvent_ion_probe_radii": 0.8, "pdbx_solvent_shrinkage_radii": 0.8, "pdbx_solvent_vdw_probe_radii": 1.4, "pdbx_starting_model": "PDB ENTRY 2VVC", "pdbx_stereochemistry_target_values": "MAXIMUM LIKELIHOOD", "solvent_model_details": "BABINET MODEL WITH MASK", "biso_mean": 25.79}], "refine_hist": [{"cycle_id": "LAST", "d_res_high": 1.61, "d_res_low": 74.54, "number_atoms_solvent": 240, "number_atoms_total": 2453, "pdbx_number_atoms_ligand": 38, "pdbx_number_atoms_nucleic_acid": 0, "pdbx_number_atoms_protein": 2175, "pdbx_refine_id": "X-RAY DIFFRACTION"}], "refine_ls_restr": [{"dev_ideal": 0.011, "dev_ideal_target": 0.022, "number": 2348, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_bond_refined_d"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_bond_other_d"}, {"dev_ideal": 1.381, "dev_ideal_target": 1.966, "number": 3169, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_angle_refined_deg"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_angle_other_deg"}, {"dev_ideal": 5.579, "dev_ideal_target": 5.0, "number": 290, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_1_deg"}, {"dev_ideal": 33.275, "dev_ideal_target": 23.81, "number": 105, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_2_deg"}, {"dev_ideal": 11.833, "dev_ideal_target": 15.0, "number": 407, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_3_deg"}, {"dev_ideal": 15.012, "dev_ideal_target": 15.0, "number": 16, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_dihedral_angle_4_deg"}, {"dev_ideal": 0.092, "dev_ideal_target": 0.2, "number": 336, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_chiral_restr"}, {"dev_ideal": 0.006, "dev_ideal_target": 0.021, "number": 1789, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_gen_planes_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_gen_planes_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbd_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbd_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbtor_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_nbtor_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_xyhbond_nbd_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_xyhbond_nbd_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_metal_ion_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_metal_ion_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_vdw_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_vdw_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_hbond_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_hbond_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_metal_ion_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_symmetry_metal_ion_other"}, {"dev_ideal": 0.796, "dev_ideal_target": 1.5, "number": 1428, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcbond_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcbond_other"}, {"dev_ideal": 1.412, "dev_ideal_target": 2.0, "number": 2293, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcangle_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_mcangle_other"}, {"dev_ideal": 1.966, "dev_ideal_target": 3.0, "number": 920, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scbond_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scbond_other"}, {"dev_ideal": 3.082, "dev_ideal_target": 4.5, "number": 876, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scangle_it"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_scangle_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_long_range_B_refined"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_long_range_B_other"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_rigid_bond_restr"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_sphericity_free"}, {"pdbx_refine_id": "X-RAY DIFFRACTION", "type": "r_sphericity_bonded"}], "reflns": [{"d_resolution_high": 1.61, "d_resolution_low": 50.0, "number_obs": 36756, "observed_criterion_sigma_i": -3.0, "pdbx_rmerge_iobs": 0.05, "pdbx_diffrn_id": ["1"], "pdbx_net_iover_sigma_i": 22.8, "pdbx_ordinal": 1, "pdbx_redundancy": 7.2, "percent_possible_obs": 99.4}], "reflns_shell": [{"rmerge_iobs": 0.36, "d_res_high": 1.61, "d_res_low": 1.7, "mean_iover_sig_iobs": 5.85, "pdbx_diffrn_id": ["1"], "pdbx_ordinal": 1, "pdbx_redundancy": 6.75, "percent_possible_all": 100.0}], "software": [{"classification": "refinement", "name": "REFMAC", "pdbx_ordinal": 1, "version": "5.4.0077"}, {"classification": "data reduction", "name": "XDS", "pdbx_ordinal": 2}, {"classification": "data scaling", "name": "XDS", "pdbx_ordinal": 3}, {"classification": "phasing", "name": "MOLREP", "pdbx_ordinal": 4}], "struct": {"pdbx_descriptor": "ACTIVATED FACTOR XA HEAVY CHAIN (E.C.3.4.21.6), FACTOR X LIGHT CHAIN (E.C.3.4.21.6)", "title": "Aminopyrrolidine Factor Xa inhibitor"}, "struct_keywords": {"pdbx_keywords": "BLOOD CLOTTING", "text": "HYDROLASE, CATION, PLASMA, CALCIUM, ZYMOGEN, PROTEASE, INHIBITOR, POLYMORPHISM, GLYCOPROTEIN, GAMMA-CARBOXYGLUTAMIC ACID, BLOOD CLOTTING, COAGULATION FACTOR, HYDROXYLATION, SERINE PROTEASE, EGF-LIKE DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES"}, "symmetry": {"int_tables_number": 96, "space_group_name_hm": "P 43 21 2"}, "rcsb_id": "2VWN", "rcsb_binding_affinity": [{"comp_id": "H25", "type": "Ki", "value": 10.0, "unit": "nM", "reference_sequence_identity": 99, "provenance_code": "BindingDB", "link": "http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=2VWN"}, {"comp_id": "H25", "type": "Ki", "value": 10.0, "unit": "nM", "provenance_code": "PDBBind", "link": "http://www.pdbbind-cn.org/quickpdb.php?quickpdb=2vwn"}]}